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Research
2,4-dichlorophenoxyacetic acid (2,4-D) is a
widely used herbicide with agricultural and
nonagricultural applications. In the United
States in 2001, 2,4-D ranked ﬁfth among all
pesticides in pounds of active ingredient
applied in the agricultural market sector
(28–33 million lb), the number one pesticide
applied in both the home and garden market
sector (8–11 million lb), as well as the indus-
try, commercial and government market sec-
tor (16–18 million lb) (Donaldson et al.
2004). Studies of health outcomes related to
chronic exposure to 2,4-D exposure have
shown inconsistent results (Bukowska 2003;
Burns et al. 2001; Figgs et al. 2000;
Garabrant and Philbert 2002; Garry et al.
2001; Zahm et al. 1990), which may be
attributed largely to difﬁculties with exposure
characterization.
Unlike studies of industrial pesticide
manufacturing workers, which often use per-
sonnel and industrial hygiene records to
reconstruct exposure histories, epidemiologic
studies of herbicide exposure in farmers,
farmworkers, and farm families have generally
relied on self-reported activity-based ques-
tionnaires to estimate exposure potential. The
validity of questionnaire data for determining
exposures within the agricultural populations
has not been established, but a few studies
that have addressed the issue indicate the
validity is variable (Blair et al. 2002; Engel
et al. 2001). Farmers report general pesticide
usage practices with reasonable reliability, but
the validity of reporting speciﬁc chemicals is
problematic (Blair and Zahm 1993; Engel
et al. 2001). The magnitude of exposure has
especially been difficult to quantify for farm
family members, including the primary appli-
cator. Pesticide use is clearly the primary
determinant of exposure for applicators, but
characterizing exposure intensity within popu-
lations of applicators is difficult. Notable
efforts to improve exposure estimates are often
based on other exposure surrogates (Dosemeci
et al. 2002). However, developing valid expo-
sure models based on these surrogates is an
elusive undertaking; such models must be
developed with relevant biological monitoring
data (Acquavella et al. 2006; Arbuckle et al.
2002). To better characterize exposure from
herbicide use, we present biomonitoring
results from the Farm Family Exposure Study
(FFES) evaluating 2,4-D exposure in farm
family members following a single application
as part of usual farm practice.
Methods
This study was approved by the Human
Subjects Research Committee of the University
of Minnesota and followed all applicable
requirements and regulations. The target popu-
lation was families living and working on an
agriculture production operation where pesti-
cides are used routinely. The methods for this
study are described in detail elsewhere (Baker
et al. 2005), and more information about the
study is available on the study website (FFES
2004). Briefly, families were identified from
lists of licensed pesticide applicators in
Minnesota (n = 25,301) and South Carolina
(n = 10,805). In addition to logistical consider-
ations, Minnesota and South Carolina were
selected as two states representing a diversity of
agricultural practices, thus making study results
more generalizable to other research. The
licensed applicators were randomly ordered and
contacted sequentially ﬁrst by mail and then by
telephone for recruitment into the study.
Eligibility for the study required that a) the
family lived on a farm, b) the family consisted
of the farmer, a spouse, and at least one child
4–17 years of age, c) the farmer was planning to
personally apply 2,4-D as part of the normal
operation to at least 10 acres of cropland, some
of which had to be within 1 mile, and on a
contiguous piece of land with the family home,
and d) the family members were willing to
collect all of their urine for 5 days.
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OBJECTIVE: We estimated 2,4-dichlorophenoxyacetic acid (2,4-D) exposure and systemic dose in
farm family members following an application of 2,4-D on their farm. 
METHODS: Farm families were recruited from licensed applicators in Minnesota and South
Carolina. Eligible family members collected all urine during five 24-hr intervals, 1 day before
through 3 days after an application of 2,4-D. Exposure proﬁles were characterized with 24-hr urine
2,4-D concentrations, which then were related to potential predictors of exposure. Systemic dose
was estimated using the urine collections from the application day through the third day after
application. 
RESULTS: Median urine 2,4-D concentrations at baseline and day after application were 2.1 and
73.1 µg/L for applicators, below the limit of detection, and 1.2 µg/L for spouses, and 1.5 and 2.9
µg/L for children. The younger children (4–11 years of age) had higher median post-application
concentrations than the older children (≥ 12 years of age) (6.5 vs. 1.9 µg/L). The geometric mean
systemic doses (micrograms per kilogram body weight) were 2.46 (applicators), 0.8 (spouses), 0.22
(all children), 0.32 (children 4–11 years of age), and 0.12 (children ≥ 12 years of age). Exposure to
the spouses and children was primarily determined by direct contact with the application process
and the number of acres treated. Multivariate models identiﬁed glove use, repairing equipment, and
number of acres treated as predictors of exposure in the applicators. 
CONCLUSIONS: We observed considerable heterogeneity of 2,4-D exposure among farm family
members, primarily attributable to level of contact with the application process. Awareness of this
variability and the actual magnitude of exposures are important for developing exposure and risk
characterizations in 2,4-D–exposed agricultural populations.
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14 December 2006]Eligible families were provided with
comprehensive information about the study
and taken through an informed consent
process. The family received written informa-
tion about the study procedures, risks, and
beneﬁts. This was followed by a meeting with a
study representative who reviewed the protocol
and answered any questions from the family.
Signed consent was obtained from the appli-
cator and spouse, a signed parental consent
form was obtained for the children to partici-
pate, and signed assent forms were obtained
from children 8–17 years of age and verbal
assent was obtained for children < 8 years of
age. A study start date was estimated based on
predicted 2,4-D application date. The actual
date of application was flexible to allow for
changes brought on by weather and other
needs of the farm. Participating families
received $250 and an additional $50 for each
child that participated. In addition, the cost
of the chemical used in the study application
was reimbursed up to a maximum of $1,000
(median reimbursement $207). All applica-
tions were conducted in the 2000 and 2001
growing seasons. Ultimately 34 applications
of 2,4-D were observed, 17 in South Carolina
and 17 in Minnesota. 
The families were instructed to follow
their normal routines related to pesticide
application. The intent of the study was to
measure exposure in real-world conditions, so
no restrictions were made pertaining to the
purchase of the chemical, when and how the
farmers applied the chemical and maintained
their equipment, how and when they changed
or washed their clothes used in the applica-
tion, whether the spouse and children were
present when the application was made, and
whether other chemicals were applied. 
The farmer and spouse were asked to com-
plete an enrollment questionnaire before and a
follow-up questionnaire after the study applica-
tion. The questionnaires emphasized the fol-
lowing: demographics, farm production and
practices, pesticide application procedures, use
of personal protective equipment, self-reported
exposures including recent pesticide applica-
tions, activities at the time of the study pesti-
cide application, and potential exposure to the
children. The questionnaires were reviewed for
completeness and participants were recon-
tacted for missing information. 
A research team member observed the
chemical application and recorded the location
and size of the ﬁeld, proximity to the house,
equipment used, chemical name and formula-
tion, methods of mixing, personal protective
equipment used, clothing worn, occurrence of
spills, accidents, or repairs of the equipment,
and presence of children, spouse, or pets dur-
ing the mixing and application process. 
The farmer, spouse, and participating chil-
dren were asked to collect all urine voids for
5 days: the day before pesticide application
through 3 days after pesticide application—
hereafter referred to as days –1, 0, 1, 2, and 3.
Each void was collected into 500-mL high-
density polyethylene single-void containers.
The family was provided with coolers and ice
packs or a small refrigerator to store the urine.
The date and time of each void was recorded
by the study participants and logged by study
staff when the urine specimens were picked up
daily. If one or more of the family appeared to
have low volumes or few voids, the farmer or
spouse was asked to encourage the family to
fully comply with the study protocol. The
individual urine voids were refrigerated, com-
bined proportionally by volume into 24-hr
composite samples representing all urine
voided in that period, and then frozen. The
24-hr urine composite samples were timed in
24-hr intervals based on the exact time the
2,4-D mixing and application process began
on the day of application (day 0), including
the 24 hr preceding initial contact (day –1)
and the 3 24-hr periods following day 0
(days 1, 2, and 3).
2,4-D is excreted in the urine as 2,4-D or
a 2,4-D conjugate (Sauerhoff et al. 1977). To
estimate exposure, we analyzed the composite
urine samples for 2,4-D, using a sensitive,
selective method developed to measure both
3,5,6-trichloropyridinol (TCP; a metabolite of
chlorpyrifos) and 2,4-D (Brzak and Bartels
2001). The analyte was hydrolyzed with con-
centrated hydrochloric acid to the nonconju-
gated form and extracted into toluene. The
organic extracts were treated with N-methyl-
N-(tert-butyl-dimethylsilyl)-triﬂuoroacetamide
to form the tert-butyl-dimethylsilyl derivatives
of 2,4-D. Analysis was accomplished by gas
chromatography/mass spectrometry operating
in the negative ion chemical ionization mode,
and quantitation was performed using deriva-
tized solvent standards. An isotopically labeled
internal standard, 13C6-2,4-D, was used in the
method. The intraday analysis of relative
recovery, across the concentration range of
1–500 µg/L, afforded relative recoveries of
85–90%. These results indicate minimal
matrix effects for this assay. The limit of quan-
titation was 1 µg/L. The results were corrected
for laboratory fortification relative recovery
results. No correction was made for recovery
from ﬁeld and travel spikes because the recov-
eries were just over 100% on average and the
correction would only marginally decrease the
estimated exposure.
Creatinine concentration in the 24-hr
sample was measured and used to estimate the
total creatinine in the urine collected over the
24-hr period. The creatinine analysis was per-
formed by a spectrophotometric method and
using a Kinetic Creatinine Procedure Kit pro-
vided by Data Medical Associates (Arlington,
TX). The creatinine corrected concentration
of 2,4-D was expressed as micrograms 2,4-D
per gram total creatinine. 
In addition to exposure assessment, we esti-
mated systemic dose to aid risk characterization
models. In risk characterization models, the
relevant 2,4-D dose includes 2,4-D from all
sources. The dose estimates for this study were
based on total 2,4-D excretion over the entire
postapplication period, which includes back-
ground concentration, exposure due to this
application, and other sources. The daily total
urine volumes were multiplied by the 2,4-D
concentration from the composite sample to
estimate daily exposure on the application day
through day 3. We calculated a mean elimina-
tion rate for urinary 2,4-D from the applicator’s
urinary 2,4-D data, using the sigma-minus
method (Gibaldi and Perrier 1975), and this
rate assumes that 93% of the absorbed 2,4-D is
recovered in the urine (Sauerhoff et al. 1977). 
We generated measures of central tendency
(mean, median, range, and geometric mean) of
the daily and the maximum urine 2,4-D con-
centrations for the applicators, spouses, and
children to evaluate the data. A value of 0.5
µg/L, the midpoint from 0 to the limit of
detection (LOD; 1 µg/L) was imputed for con-
centrations below the LOD. The distribution
of concentrations was highly skewed; thus we
used medians, geometric means, and geometric
standard deviations to further characterize the
central tendency of the exposures. We calcu-
lated the median change from baseline for daily
2,4-D urine concentrations and creatinine-cor-
rected concentrations to characterize the expo-
sure over the study period. We used 95%
conﬁdence intervals (CIs) to describe the preci-
sion of these estimates. We compared the dif-
ferences in the baseline concentrations and
estimated systemic dose between applicators,
spouses, and children using both a nonpara-
metric sign test to compare the differences in
medians, and paired t-tests to compare the dif-
ferences in the log of the doses; both analyses
showed similar results. All analyses were con-
ducted with PC SAS version 9.1 (SAS Institute
Inc., Cary, NC).
Incomplete urine collections will introduce
error in systemic dose estimates by under-
estimating the total amount of chemical
excreted. To evaluate this error, we conducted
a sensitivity analysis by imputing a ﬂoor vol-
ume for daily 24-hr urine samples. Using all
24-hr urine collections from the FFES (n =
1,895) (Baker et al. 2005), we assigned the
25th percentile of the volume for the applica-
tors, spouses, and children 4–6, 7–9, 10–12,
and ≥ 13 years of age to any 24-hr collection
below that value. The systemic doses were
recalculated using these adjusted volumes and
compared to the original estimates. 
Determinants of exposure are described
by the geometric mean and standard devia-
tion of the 24-hr sample with the highest
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Indicators of exposure for the children and
spouses recorded by the observer included the
closest distance from the field to the house,
the number of acres treated, the number of
loads, presence of the child or spouse during
the application, and observation of opportu-
nity for direct contact with the chemical
(working with applicator, contact with equip-
ment, or treated field). We evaluated self-
report of washing the clothes used in the
application as a determinant of exposure for
the spouse. To evaluate potential differences
by age, the children were stratified at 4–11
and ≥ 12 years of age, a cut point used in the
Centers for Disease Control and Prevention’s
(CDC) Third National Report on Human
Exposure to Environmental Chemicals (CDC
2005). We evaluated the exposure to the
applicator with reference to application prac-
tices. Categories were compared for the num-
ber of acres treated, number of loads (each
time the tank was ﬁlled), observed skin con-
tact, spills or accidents, any use of protective
rubber gloves during mixing or application,
repair of equipment, and tobacco use and eat-
ing during the application. These exposures
were further evaluated by whether the applica-
tor used gloves at any time during the applica-
tion process. Single and multivariable
generalized linear models were ﬁt to examine
statistical associations for linear and categorical
exposure determinants and the natural log of
the maximum daily concentration (SAS
Institute Inc.). 
Results
The 34 licensed applicators applying 2,4-D
were male (Table 1). Fifty-three children
4–17 years of age participated in the study.
Two of the children were reported to have
applied 2,4-D the week before the study
application; however for one, a 5-year-old
with no detectable 2,4-D preapplication, it
was unclear whether this was correct because
it was reported by only one parent and no
date of use was given. No applicators or
spouses reported mixing or applying 2,4-D
before the study application date, but ﬁve had
baseline concentrations substantially above
the median (55, 63, 194, 199, and 230 µg/L).
All of these had substantial changes from
baseline with maximum postapplication con-
centrations of 310, 686, 1,708, 2,236, and
439 µg/L. Twenty children and eight spouses
were present at some time during the applica-
tion process, but only one spouse and four
children were observed to have the opportu-
nity for direct contact with the chemical dur-
ing the application. Application methods
were uniform for this chemical and were
made with a boom sprayer; two applications
also used hand wands at some time for por-
tions of the application. The formulations
were all liquid, either emulsiﬁable concentrate
or aqueous solution and included both 2,4-D
amine (n = 21) and ester (n = 13) formula-
tions. The application acreages ranged from
10 to 281 and required 1–14 loads.
At least one urine void from all participants
was available for the day before application and
application day. One applicator and one
spouse were missing samples for day 3. Seven
samples were missing from children: day 1 (1),
day 2 (1), and day 3 (5). 
The median preapplication 2,4-D concen-
tration was higher for applicators (2.1 µg/L)
than for children (1.5 µg/L) and spouses
(0.5 µg/L—the LOD) (Table 2). The differ-
ences in the medians, though modest, were
statistically signiﬁcant by the sign test between
the applicators and spouses (< 0.0001) and
children (p = 0.0004), and spouses and chil-
dren (p = 0.0013). The postapplication con-
centrations for the applicators were highly
skewed and were much higher than those for
Alexander et al.
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Table 1. Characteristics of farm families that applied 2,4-D in the FFES (no.). 
Characteristic Applicators Spouse Children
Sex
Male 34 0 31
Female 0 34 22
Age (years)
Mean (range) 43.6 (31–58) 40.2 (30–60) 10.1 (4–17)
Mix or apply 2,4-D in previous weeka
Yes 0 0 2
No 34 34 51
Present during applicationb
Yes 34 8 20
No 0 26 33
Opportunity for direct contact with chemicalb,c
Yes 16 1 4
No 18 33 49
aAs reported on applicator and spouse enrollment questionnaire. bReported by ﬁeld observer. cSkin contact for applica-
tor; for children and spouse working with applicator, contact with equipment, or treated ﬁeld.
Table 2. Summary of urine 2,4-D concentrations by volume and per gram creatinine by study day with
change from baseline.
Applicators Spouses Children
Study day µg/La µg/gb µg/L µg/g µg/L µg/g
Preapplication
No. 34 34 34 34 53 53
Medianc 2.1 1.5 0.5 0.5 1.5 1.1
Range (minimum–maximum)  0.5–230.9 0.1–130 0.5–20.4 0.5–20.4 0.5–53.2 0.1–48.6
GM 3.8 2.1 1.0 0.9 1.4 1.2
Application
No. 34 34 34 34 53 53
Median 21.3 17.1 0.5 0.8 1.8 1.6
Range (minimum–maximum) 0.5–452.6 0.4–148 0.5–15.9 0.2–21.6 0.5–336.2 0.2–190.9
GM 29.1 16.3 1.0 0.9 2.1 1.9
Median change from baseline  17.8 13.9 0.0 0.0 0.0 0.3
(95% CI) (11.0–62.8) (6.6–28.4) (0.0–0.5) (–0.2–0.3) (0.0–0.9) (0.0–0.7)
Day 1
No. 34 34 34 34 52 52
Median 73.1 45.8 1.2 1.1 2.9 2.3
Range (minimum–maximum) 1.5–1856.0 1.1–533.8 0.5–20.0 0.2–13.1 0.5–640.4 0.3–660.2
GM 64.2 33.4 1.3 1.2 3.6 3.1
Median change from baseline 70.7 43.0 0.0 0.2 2.1 0.8
(95% CI) (31.7–123.4) (13.4–77.7) (0.0–1.2) (–0.2–0.8) (0.0–3.0) (0.3–2.8)
Day 2
No. 34 34 34 34 52 52
Median 80.2 37.5 1.3 0.9 3.4 2.6
Range (minimum–maximum) 0.5–2236.0 0.4–822 0.5–24.9 0.2–16.3 0.5–263.3 0.3–135.4
GM 45.3 23.7 1.4 1.2 3.5 2.9
Median change from baseline 74.7 33.3 0.1 0.1 1.6 0.8
(95% CI) (25.1–103.6) (10.3–70.5) (0.0–0.7) (–0.1–0.7) (0.6–3.5) (0.6–2.3)
Day 3
No. 33 33 33 33 48 48
Median 34.3 21.3 0.8 0.9 3.0 3.0
Range (minimum–maximum) 0.5–1529.2 0.4–580 0.5–15.9 0.5–8.8 0.5–97.9 0.3–117.8
GM 28.3 16.2 1.3 1.1 3.4 3.0
Median change from baseline 27.3 16.3 0.0 0.0 1.5 1.6
(95% CI) (10.8–54.1) (6.8–36.1) (0.0–0.7) (–0.2–0.5) (0.8–3.5) (0.7–3.2)
GM, geometric mean.
aµg/L 2,4-D concentration in urine. bµg/g 2,4-D per gram creatinine. cSign test for difference in medians between the
applicators and spouses (< 0.0001), applicators and children (p = 0.0004), and spouses and children (p = 0.0013). children and spouses (Table 2). The geometric
mean maximum concentration for the applica-
tors was 64.2 µg/L and occurred on the day
after application. There was not an apparent
peak for children and spouses, and the geomet-
ric means varied little across the study period.
However, the highest concentration for a child
(640.4 µg/L) occurred on day 1 in a child who
assisted with the application. The median
change from baseline was highest (74.7; 95%
CI, 25.1–103.6) for the applicators on day 2.
The concentrations in the spouse following
application were not statistically different from
baseline. The change from baseline for the chil-
dren was highest on day 3 (1.5 µg/L; 95% CI,
0.8–3.5). The relative patterns were similar for
creatinine corrected urine 2,4-D concentra-
tions. The results expressed as micrograms
analyte per gram creatinine are presented to
allow comparison to other research addressing
similar age and sex categories. 
2,4-D was detectable in 70% of the appli-
cators, 62% of the children, and 41% of the
spouses at baseline (Table 3). The results were
similar between older and younger children.
The postapplication maximum concentration
for the children 4–11 years of age was some-
what higher than for children ≥ 12 years of
age. The geometric mean estimated systemic
dose over the period of the study was 2.46,
0.08, and 0.22 µg/kg body weight for the
applicators, spouses, and children, respectively
(Table 3). The geometric mean dose for the
younger children was nearly 3-fold greater
than for the older children; however, the
range of the doses for the older children was
much greater, with a maximum dose of 31.07
versus 7.16 µg/kg, which is attributable to
contact with the application process. Eight
applicators and one child exceeded 10 µg/kg.
The sensitivity analysis that set a minimum
volume for each 24-hr period did not change
the overall distribution. The adjusted geomet-
ric means were 2.52, 0.09, 0.32, and 0.12
µg/kg body weight for the applicators,
spouses, children 4–11 years of age, and chil-
dren ≥ 12 years of age, respectively. 
The log of the maximum postapplication
urine 2,4-D concentrations was correlated
with the number of acres treated for the
spouses (β = 0.0099, p = 0.03) and older chil-
dren (β = 0.0199, p = 0.004), but not in the
younger children (β = 0.0052, p = 0.17)
(Table 4). This association remained among
spouses and children who were not present at
the application. Spouses who were present at
some time during the application had higher
urine 2,4-D concentrations than those not
present (β = 0.779, p = 0.094), and the one
spouse who was observed to potentially have
direct contact with the process had a higher
urine 2,4-D concentration (18.2 µg/L).
Children who were present at any time dur-
ing the application had higher exposure than
those who were not (geometric mean = 9.6 vs.
3.3 µg/L; p = 0.011). The concentrations var-
ied by sex as well as age in the children, with
the younger girls and older boys having
higher concentrations (Table 4), but the con-
centrations were not statistically different. 
The number of acres, number of loads,
observed skin contact, and repairing equip-
ment during the application were all positively
associated with urine 2,4-D concentrations
among the applicators (Table 5). The use of
gloves during the mixing and application
process reduced exposure dramatically, with
the geometric mean urine concentration for
applicators not wearing gloves > 7-fold greater
(236 vs. 44 µg/L). The use of tobacco, eating
during the application, not having a closed
cab, and washing the equipment were not
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Table 3. Maximum daily 2,4-D concentrationsa and estimated 2,4-D doseb across all study days for all par-
ticipants by farm family member. 
Children
Applicator Spouse All 4–11 years ≥ 12 years
No. 34 34 53 33 20
Detectable preapplication (%) 70.6 41.2 62.3 63.6 60.0
Detectable any day (%) 100.0 67.6 88.7 90.9 85.0
Maximum urine 2,4-D (median) 90.9 1.7 4.7 6.5 1.9
Concentration (µg/L)
Range 1.5–2236.0 0.5–24.9 ND–640.4 0.5–109.9 0.5–640.4
GM 71.9 1.7 4.9 6.4 3.2
GSD 6.2 3.2 4.5 4.0 5.1
Dose (µg/kg)b
GM 2.46 0.08 0.22 0.32 0.12
All days
GSD 5.66 2.59 4.60 3.50 5.92
Maximum 58.48 1.14 31.07 7.16 31.07
90th percentile 23.99 0.25 1.07 1.07 1.44
75th percentile 9.28 0.16 0.46 0.53 0.20
Abbreviations: GM, geometric mean; GSD, geometric standard deviation; ND, not detectable.
aµg/L 2,4-D LOD was assigned to 0.5 µg/L. bU.S. EPA RfD = 0.01 mg/kg/day, or 10 µg/kg/day. p-Value for difference in log of
dose between farmer and all children, farmer and children 4–11 years of age, farmer and spouse, spouse and children,
and spouse and children 4–11 years of age: p < 0.0001; for spouse and children ≥ 12 years of age, p = 0.32. 
Table 4. Geometric means and standard deviations of the maximum urine 2,4-D concentration from 24-hr
samples for spouses and children 4–11 and ≥ 12 years of age by potential exposure surrogate. 
Children (age)
Spouses 4–11 ≥ 12
Exposure metric No. GM GSD No. GM GSD No. GM GSD
State
Minnesota 17 2.0 3.1 19 7.3 2.9 11 3.6 3.2
South Carolina 17 1.5 3.3 14 5.3 5.7 9 2.8 8.5
Sex
Female 34 1.7 3.2 18 8.5 3.0 13 2.7 6.6
Male 15 4.5 5.1 7 4.5 2.9
Distance from house (yards)
< 75 9 1.6 3.5 5 5.0 2.7 8 3.6 9.1
75–175 8 3.1 2.8 7 6.1 5.1 5 3.99 3.8
175–600 8 1.8 2.8 11 8.2 2.1 4 4.1 3.4
> 600 9 1.0 3.3 10 5.6 7.1 3 1.3 2.7
Acres treated
< 25 9 1.2 3.7 8 5.5 9.5 7 1.8 2.9
25–< 50 3 1.1 2.1 4 2.2 3.0 1 19.8
50–< 75 7 1.9 2.4 5 12.8 3.9 5 2.3 1.8
≥ 75 15 2.3* 3.4 16 7.2 2.0 7 5.7* 10.7
Loads mixed and applied
1–2 9 1.1 2.6 8 4.1 4.8 5 4.1 3.1
3–5 14 1.8 3.7 16 7.4 4.4 8 2.1 3.4
≥ 6 11 2.3 2.9 9 7.3 2.8 7 4.4 10.3
Present at some time during application
Yes 8 3.1 2.9 12 11.5 4.1 8 7.3 8.8
No 26 1.4 3.1 21 4.6 3.6 12 1.9 2.4
Direct contact opportunitya
Yes 1 18.3 2 108.6* 1.02 2 17.9* 157.5
No 33 1.6 3.0 31 5.3 3.4 18 2.7 2.8
Wash pesticide application clothes 
Yes 22 1.8 3.1
No 12 1.6 3.4
Abbreviations: GM, geometric mean; GSD, geometric standard deviation. 
aObserved by ﬁeld observer; working with applicator, contact with equipment, or treated ﬁeld. *p < 0.05 highest to lowest
category. associated with exposure in the univariate
analysis. The difference in exposure by glove
use was observable across all covariates; appli-
cators who wore gloves had consistently lower
urine 2,4-D concentrations (Table 6).
Multivariate models determined that three
covariates—wearing gloves, acres treated, and
repairing equipment—were consistently pre-
dictive of exposure (Table 7). Some covariates,
such as glove use and observed skin contact,
were highly correlated and could not be
included in the model together. The number
of loads, though correlated with the number
of acres, was not predictive in the multivariate
models, despite being an indicator of increased
potential for direct contact with the chemical. 
Discussion
In this study, the application of 2,4-D to crop
land resulted in exposure to the applicator and
some other family members, but the magni-
tude of exposure is determined by the potential
for direct contact with the application process
or chemical. Overall, exposure to the children
and spouses was low, and was minimal or
below detection for those who did not have
contact with the application process. Some
putative determinants of exposure to applica-
tors were predictive of exposure—primarily use
of gloves, size of application, and having to
repair equipment—but the effect of other
commonly cited exposure modiﬁers could not
be distinguished. These results have implica-
tions for pesticide exposure assessment and risk
characterizations for farm families. The results
also emphasize recognized exposure pathways
that can be modified to reduce exposure:
specifically reducing children’s potential for
contact with the application process.
Most of the applicators and children had
detectable urine concentrations of 2,4-D at
baseline, whereas the spouses had a somewhat
lower frequency of detectable concentrations.
These baseline concentrations differ from
other published population-based urine con-
centrations. The 2001–2002 National Health
and Nutrition Examination Survey measured
2,4-D in spot samples of participants
throughout the country and reported
detectable concentrations in children 6–11
and 12–19 years of age; adult males had
detectable concentrations at the 75th per-
centile (0.3, 0.25, and 0.1µg/L respectively)
and adult females at the 90th percentile (0.48
µg/L) (CDC 2005). Curwin et al. (2005)
reported similar prevalence of detectable
2,4-D urine concentrations in farmers who
had not applied 2,4-D. The geometric mean
concentrations for farmers who applied 2,4-D
were lower than those in our study, but the
timing of the samples in relation to applica-
tion did not always capture the peaks in excre-
tion (Curwin et al. 2005). Compared to a
study of farm families in Ontario, Canada
(Arbuckle et al. 2004), families in our study
had a higher prevalence of detectable concen-
trations in children (60 vs. 9.8%) and a higher
maximum concentration in children (640 vs.
100 µg/L). The differences in background
concentrations could be attributable to sam-
pling methods, calendar period of exposure
characterization, or higher environmental
Alexander et al.
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Table 5. Selected determinants of the maximum
urine 2,4-D concentration from 24-hr samples for
applicators.
Exposure
metric No. GM GSD p-Value
State
Minnesota 17 76.4 7.9 0.851
South Carolina 17 67.7 5.0
Acres treated 
< 25 9 57.0 5.2 0.007a
25–< 50 3 12.9 4.9
50–< 75 7 100.9 7.5
≥ 75 15 99.7 6.3
Loads mixed and applied
1–2 9 53.0 7.1 0.023a
3–5 14 50.5 7.4
≥ 6 11 144.8 4.0
Skin contact observed 
Yes 16 188.8 4.3 0.002
No 18 30.5 5.7
Closed cab on tractor
Yes 15 61.4 9.1 0.66
No 19 81.5 4.6
Any spill or accident observed
Yes 12 115.4 6.7 0.27
No 22 55.6 5.8
Wore rubber gloves during process
Yes 24 43.8 5.9 0.01
No 10 236.2 4.0
Repaired equipment during application
Yes 13 184.1 3.6 0.016
No 21 40.2 6.7
Reported washing application equipment
Yes 21 69.4 6.4
No 13 76.2 6.5 0.880
Used tobacco during application
Yes 11 106.7 5.3 0.392
No 23 59.6 6.7
Ate during application
Yes 4 140.1 3.8 0.44
No 30 65.8 6.6
Abbreviations: GM, geometric mean; GSD, geometric stan-
dard deviation. 
aLinear trend: natural log of the 2,4-D concentration and
the number of acres or loads.
Table 6. Selected determinants of the maximum urine 2,4-D concentration (µg/L) from 24-hr samples for
applicators by use of protective rubber gloves. 
No Yes
Exposure metric No. GM GSD No. GM GSD
Acres treated 
< 25 3 347.0 1.9 6 23.1 3.1
25–< 50 0 — — 3 12.9 4.9
50–< 75 1 202.4 — 6 89.9 8.9
≥ 75 6 199.9 6.0 9 62.7 6.2
Loads mixed and applied
1–2 1 207.8 44.7 8 44.7 7.6
3–5 2 621.7 33.2 12 33.2 6.2
≥ 6 7 182.4 96.7 4 96.7 3.4
Skin contact observed 
Yes 7 329.9 3.8 9 122.4 4.3
No 3 108.2 4.2 15 23.7 5.6
Any spill or accident
Yes 5 409.9 3.1 7 46.7 6.9
No 5 136.1 4.6 17 42.7 5.9
Repaired equipment during application
Yes 6 247.6 3.3 7 142.8 4.1
No 4 220.0 6.4 17 26.9 5.6
Used tobacco during application
Yes 6 211.7 4.3 5 46.9 5.4
No 4 278.2 4.5 19 43.0 6.4
Ate during application
Yes 1 292.9 — 3 109.6 4.6
No 9 230.6 4.4 21 38.5 6.1
Abbreviations: —, GSD not calculated; GM, geometric mean; GSD, geometric standard deviation.
Table 7. Final regression models for predictors of the log of the maximum urine 2,4-D concentration for the
applicator.
Covariate, metric β SE 95% CI p-Value
Wore rubber gloves 
Yes Referent
No 1.0108 0.58548 –0.18489–2.20654 0.0945
Repaired equipment
No Referent
Yes 1.2238 0.53906 0.12295–2.32475 0.0305
Acres treated
Acre 0.01263 0.00453 0.00336–0.02189 0.0092
R2 = 0.4208.concentrations. The urine samples for the
FFES were all collected in the spring and
early summer when use of the chemical is at
its highest for agricultural and nonagricultural
purposes. The LOD for our study and that of
Arbuckle et al. (2004) are equivalent (1 µg/L),
and modestly higher than the CDC method
(0.2 µg/L) (2005); thus the difference in
prevalence of exposure is unlikely attributable
to laboratory methods. Higher background
levels in farm families are also plausible as a
result of low-level contamination of the living
area. A study of households in a corn and soy-
bean region of Iowa reported 2,4-D to be the
most prevalent of several herbicides in house
dust samples, and the concentrations of all
herbicides was associated with proximity to
crops (Ward et al. 2006). The houses from a
subsample of participants in the Agricultural
Health Study in Iowa had 2,4-D detected in
all house dust samples, and the concentration
was associated with spray applications
(Curwin et al. 2005). The Ontario Farm
Family Health Study also reported residual
contamination of several household surfaces
with 2,4-D (Arbuckle et al. 2006).
The collection of sequential 24-hr urine
samples allowed estimation of absorbed dose
over the study period. Exposure and dose are
correlated, and exposure estimates based on
biological monitoring are useful for recon-
struction of exposure for an epidemiologic
study. Risk characterization, however,
requires a more complete understanding of
absorbed dose. The reference dose (RfD) for
2,4-D established by the U.S. Environmental
Protection Agency (EPA) is 0.01 mg/kg/day,
based on a no observed adverse effect level of
1.0 mg/kg/day from a 2-year bioassay of rats
(U.S. EPA 1988). We estimated dose from all
2,4-D excreted in the urine over 4 days
postapplication. With the assumption that all
exposure from the day of application is repre-
sented in this estimate, eight applicators and
one child, who assisted in the application,
exceeded the daily reference dose for that day.
The application of herbicides occurs only a
few days out of the year, so it is difficult to
place these rare excursions above the RfD
within the prevailing risk characterization par-
adigm based on a daily dose over a lifetime.
These dose estimates do, however, provide
baseline information for risk characterization
based on an actual use scenario. 
The peak urine 2,4-D concentration in
applicators occurred on the day after applica-
tion. This peak in excretion is expected given
an approximately 17 hours biological half-life
of 2,4-D following oral administration
(Sauerhoff et al. 1977), and verifies that the
applicators are receiving most of their expo-
sure during application. The lower maximum
concentrations resulted in less dramatic peak
exposures in the spouses and children.
Although the children directly exposed to the
chemical during the application had their
greatest exposure at that point, other children
and spouses may have acquired secondary
exposure over a course of days; however, these
exposures were too low to evaluate critically.
Understanding the excretion proﬁles of herbi-
cides is useful for establishing future biomoni-
toring protocols for exposure characterization.
The FFES has demonstrated that two of the
most commonly used herbicides—glyphosate
(Acquavella et al. 2004) and 2,4-D—have
very different excretion proﬁles in farm fami-
lies. To properly ascertain maximum exposure
in pesticide biomonitoring protocols, the
chemical speciﬁc characteristics, including the
pharmacokinetics and timing of peak excre-
tion, need to be considered. This applies to
protocols using either single void or 24-hr
urine collections.
Several predictors of applicator exposure
were correlated with urine 2,4-D levels, most
of which are surrogates for potential for direct
dermal contact. The number of acres treated
and the number of loads are surrogates for the
size of application and the opportunity for
chemical contact, but also are highly corre-
lated. Both were associated with exposure in
the univariate analysis, but only acres
remained a predictor of exposure in the mul-
tivariate analysis. The use of gloves during
mixing, loading, or application reduced expo-
sure and modiﬁed the exposure levels in other
covariates. Identifying consistent predictors of
exposure for herbicide applications is difﬁcult.
Arbuckle et al. (2002) also reported glove use,
hours using 2,4-D, and tank capacity to be
associated with urine 2,4-D levels in applica-
tors; these are comparable to the predictive
skin contact and application size surrogates
that we report. Interestingly, their predictive
model for 4-chloro-2-methylphenoxyacetic
acid applications was different, although the
application methods were similar. Use of
gloves was also predictive of exposure follow-
ing boom spray applications of glyphosate
(Acquavella et al. 2004) but not for chlor-
pyrifos (Alexander et al. 2006) in the FFES.
The varying exposure scenarios for different
pesticides emphasize the need to consider not
only the use of the chemical, but also the
type of chemical and formulation in exposure
estimations.
The FFES is a comprehensive exposure
study, but is not without limitations. Overall,
the compliance with the urine collection proto-
col was good, but a few of the 24-hr urine col-
lections were incomplete (Baker et al. 2005).
Although the 2,4-D concentrations may be
well represented in these incomplete samples,
the systemic dose will be underestimated. The
applications in this study were intended to rep-
resent the real-world scenarios that a farm fam-
ily would encounter year in and year out;
however, the study was limited to a single
application. The applicators were asked to fol-
low their usual practices to capture real-world
exposure scenarios, but it is possible that some
altered practices because the ﬁeld observer was
present. Changes in equipment or agricultural
practices in the past or future may alter the
actual exposure to the family. For epidemio-
logic studies, this will be a problem largely for
reconstructing exposure in the distant past. We
recognize that intraindividual variation in
exposure may be as large as or larger than
interindividual exposure (Kromhout and
Vermeulen 2001). This study was not able to
address how much the exposure will vary over
one or more seasons and whether the peak
exposures are representative of exposures for
that individual or the distribution of expected
exposure from applying this chemical. 
The strengths of the FFES include the col-
lection of serial 24-hr urine samples, allowing
estimation of systemic dose, and adherence of
the farmers to usual practice in this exposure
characterization. This builds on the work of
Arbuckle and colleagues in establishing para-
meters for herbicide exposure (Arbuckle et al.
2002, 2004), and will aid the development and
interpretation of exposure models for epidemi-
ologic studies of pesticide-exposed populations
(Acquavella et al. 2006; Dosemeci et al. 2002).
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